http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103450163-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-416 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-12 |
| filingDate | 2012-05-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2017-06-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2017-06-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-103450163-B |
| titleOfInvention | Indazole compounds, its preparation method and its medicinal usage |
| abstract | Present invention firstly discloses a series of indazole compounds or its physiologically acceptable derivative, its preparation method and its medicinal usage.The indazole compounds or its physiologically acceptable derivative have the effect for suppressing Rho kinase activities respectively；Effect with vasodilator, protection vascular function；With the reperfusion injury effect of protection cardiac muscle cell's anti anoxia；With the effect for promoting grape cell sugar consumption；Effect with protection vascular endothelial cell to anti-oxidative damage, is class noval chemical compound with important use in terms of preparation prevents and treats the medicines such as the cardiovascular and cerebrovascular diseases such as hypertension, atherosclerosis, cerebral angiospasm, coronarospasm, myocardial infarction, heart failure and diabetic complication, diabetes. |
| priorityDate | 2012-05-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 171.